AI-Assisted chemical probe discovery for the understudied Calcium-Calmodulin Dependent Kinase, PNCK

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• The calcium-calmodulin dependent kinase family includes PNCK (CAMK1b), a kinase implicated in cancer progression and survival.
• PNCK's roles in DNA damage response, cell cycle control, apoptosis, and HIF-1-alpha pathways suggest its oncogenic relevance.
• There is a critical need for targeted small molecule inhibitors and structural data for PNCK, as none currently exist for preclinical or clinical development.

Purpose of the Study:

• To initiate the development of targeted small molecule inhibitors for PNCK.
• To identify potent chemical probes for PNCK as a potential clinical cancer target.

Main Methods:

• A multi-faceted approach combining homology modeling, machine learning, virtual screening, and molecular dynamics was employed.
• These computational methods were used to screen commercially available compound libraries.
• The goal was to identify small molecules exhibiting low-micromolar potency against PNCK activity.

Main Results:

• The study successfully identified a novel hit series of small molecules targeting PNCK.
• These compounds demonstrate low-micromolar potency against PNCK kinase activity.
• This represents the first targeted effort to discover PNCK inhibitors.

Conclusions:

• The identified hit series provides a crucial starting point for medicinal chemistry optimization.
• These findings pave the way for developing potent chemical probes for PNCK.
• This research advances the potential of PNCK as a clinical target in cancer therapy.